what does bliss pharma do

Bliss Pharma engages in the manufacturing, marketing, trading, and export of pharmaceutical formulations, including suppositories, pessaries, capsules, tablets, and syrups.

what products does bliss pharma make

Bliss Pharma produces pharmaceutical products such as suppositories, pessaries, capsules, tablets, and syrups for various medical uses.

what sector is bliss pharma in

Bliss Pharma operates in the pharmaceutical sector, specifically focusing on the development and distribution of drug formulations.

when was bliss pharma founded

Bliss Pharma was founded in 1984 and has been in operation for over three decades.

who owns bliss pharma

Bliss Pharma is a publicly traded company owned by its shareholders, with its shares listed on the National Stock Exchange of India.

Bliss GVS Pharma Limited (BLISSGVS) Share Price Today — ₹381.1

Bliss GVS Pharma Limited (BLISSGVS) live stock price is ₹381.1. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Bliss GVS Pharma Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Bliss GVS Pharma Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

BLISSGVS

BSE

Bliss GVS Pharma Limited

Healthcare· Pharmaceuticals & Biotechnology· INE416D01022· Scrip: 506197

EN हिन्दी ગુજરાતી मराठी

₹381.10

▲ 63.50 (+0.00%)

2026-05-26

BSE

₹381.10

▲ 63.50

+0.00%

244 trading days · 1Y period

TODAY (BSE)

Open321.90

High381.10

Low320.65

Prev Close317.60

Volume12.52L

Value₹44.7Cr

L: 320.65H: 381.10

Info

Face Value₹1

Listed2010-07-26

ISININE416D01022

SeriesB

BSE Scrip506197

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-3.34%

PAT+0.43%

EPS-1.73%

Profitability

EBITDA Margin26.5%

Net Margin12.3%

TTM EBITDA M.19.4%

TTM Net M.8.5%

Dividend

Yield—

Latest DPS₹0.5

Payout Ratio22.0%

Growth+0.00%

TTM Revenue

₹775 Cr

TTM EBITDA

₹150 Cr

TTM PAT

₹66 Cr

TTM EPS

₹5.55

Rev/Share

₹73.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	210 Cr	189 Cr	56 Cr	36 Cr	26 Cr	₹2.27
2024-09-30	218 Cr	187 Cr	57 Cr	36 Cr	26 Cr	₹2.31
2024-06-30	149 Cr	130 Cr	32 Cr	26 Cr	19 Cr	₹1.85
2024-03-31	198 Cr	178 Cr	6 Cr	-4 Cr	-5 Cr	₹-0.88
2023-12-31	201 Cr	166 Cr	60 Cr	40 Cr	29 Cr	₹2.64
2023-09-30	212 Cr	165 Cr	83 Cr	59 Cr	43 Cr	₹4.06
2023-03-31	185 Cr	189 Cr	5 Cr	-1 Cr	3 Cr	₹0.34
2022-12-31	206 Cr	164 Cr	71 Cr	47 Cr	30 Cr	₹2.68

Shareholding Pattern

CURRENT — 2026-03-31

Promoter35.4%

FII10.4%

DII5.0%

Public64.6%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2026-02-18	Dividend	Interim Dividend - Re 0.50 Per Share
2025-07-24	Dividend	Annual General Meeting/Dividend - Rs 0.50 Per Share
2024-07-18	Dividend	Annual General Meeting/Dividend - Rs 0.50 Per Share
2023-07-12	Dividend	Annual General Meeting/Dividend - Re 0.50 Per Share
2022-06-20	Dividend	Annual General Meeting/ Dividend - Rs 0.50 Per Share
2021-09-13	Dividend	Annual General Meeting/Dividend - Rs 0.50 Per Share
2020-09-17	Dividend	Annual General Meeting/Dividend - Rs 0.50 Per Share
2019-09-12	Dividend	Annual General Meeting/Dividend - Re 1 Per Share
2018-08-14	Dividend	Annual General Meeting/Dividend- Re 1 Per Share
2017-09-18	Dividend	Annual General Meeting/Dividend - Re 0.60 Per Share (Book Closure Dates Revised)
2016-09-06	Dividend	Annual General Meeting/Dividend Re 0.50 Per Share
2015-09-08	Dividend	Annual General Meeting/ Dividend - Re 0.50/- Per Share (Book Closure Dates Revised)
2015-02-24	Dividend	Interim Dividend - Re 0.20 Per Share
2014-08-13	Dividend	Annual General Meeting / Final Dividend - Re 0.50/- Per Share
2013-08-01	Dividend	Annual General Meeting / Dividend Rs 0.40 Per Share
2013-02-25	Dividend	Interim Dividend Rs 0.30 Per Share
2012-08-02	Dividend	Annual General Meeting / Dividend Rs 0.40 Per Share
2011-11-24	Dividend	Interim Dividend Re.0.35 Per Share
2011-07-14	Dividend	Dividend-Re.0.30 Per Share
2010-11-25	Dividend	Interim Dividend Re 0.30 Per Share

Earnings Transcripts

Bliss GVS Pharma Limited has informed the Exchange regarding Investor Presentation on Company��s per...

21 Aug 2019NSE17K chars

Read →

Bliss GVS Pharma Limited has informed the Exchange regarding Investor Presentation on Company��s per...

21 May 2019NSE19K chars

Read →

Bliss GVS Pharma Limited has informed the Exchange regarding Investor Presentation on Companys perfo...

1 Feb 2019NSE20K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-05-26	321.00	381.05	320.85	381.05	1.63Cr
2026-05-25	322.35	329.20	305.10	317.55	98.48L
2026-05-22	295.00	304.00	292.70	300.35	23.21L
2026-05-21	292.00	301.45	287.85	295.20	26.83L
2026-05-20	284.50	292.00	278.55	290.05	11.40L
2026-05-19	291.70	296.30	279.65	282.80	17.32L
2026-05-18	273.30	291.80	273.30	287.40	23.60L
2026-05-15	287.20	287.50	272.90	277.65	30.64L
2026-05-14	280.60	293.00	276.00	289.40	43.57L
2026-05-13	274.95	285.00	268.55	279.55	35.76L
2026-05-12	274.60	284.50	271.10	273.80	35.30L
2026-05-11	270.00	276.90	266.10	272.15	13.97L
2026-05-08	271.60	275.45	269.10	269.65	7.19L
2026-05-07	267.95	276.10	267.90	272.00	10.42L
2026-05-06	272.45	274.60	265.00	267.95	10.86L
2026-05-05	273.90	277.20	268.80	269.75	6.77L
2026-05-04	278.80	279.50	270.15	274.10	9.52L
2026-04-30	265.25	278.80	265.00	276.76	18.01L
2026-04-29	271.41	275.84	265.21	267.35	11.51L
2026-04-28	272.50	281.00	268.20	269.26	10.57L
2026-04-27	264.61	276.39	264.10	273.74	18.10L
2026-04-24	270.00	270.00	256.25	262.68	14.82L
2026-04-23	271.70	278.00	268.00	268.79	13.07L
2026-04-22	261.00	276.95	260.00	273.59	40.45L
2026-04-21	254.99	264.23	251.00	258.81	13.42L
2026-04-20	259.79	265.12	252.50	253.64	11.45L
2026-04-17	261.00	261.80	257.00	258.22	7.25L
2026-04-16	257.80	262.88	254.05	258.92	11.41L
2026-04-15	265.00	267.50	256.25	257.42	11.23L
2026-04-13	253.15	264.09	248.50	260.98	11.71L

Frequently Asked Questions

About

Bliss GVS Pharma Limited, listed on the NSE and BSE, is a prominent Indian pharmaceutical company established in 1984 and known for manufacturing high-quality pharmaceutical products, including a leading portfolio of suppositories and pessaries, and serving both domestic and international markets. The company is one of the largest manufacturers of these specific dosage forms and holds EUGMP certification, positioning it as a key player in the global pharmaceutical sector.